InvestorsHub Logo
Followers 192
Posts 16573
Boards Moderated 10
Alias Born 01/29/2018

Re: powerbattles post# 4620

Wednesday, 03/20/2024 11:20:14 AM

Wednesday, March 20, 2024 11:20:14 AM

Post# of 5333
There you go again with that crap. The RS is still on and valid. Once again, here is their disclosure, filed on 12-14-23, nearly 3 months after the deadline that you continue to circle to mislead everyone. That deadline was for the board to decide and act, and they did those before the deadline expired.

https://www.otcmarkets.com/otcapi/company/financial-report/389219/content

On page 12, you'll find the "Subsequent events" section, and here's what it says:

Note 11. Subsequent Events
The Company has evaluated events and transactions occurring subsequent to the consolidated balance sheet date of September 30, 2023, for items that should potentially be recognized or disclosed in these consolidated financial statements. The evaluation was conducted through December 14, 2023, the date these consolidated financial statements were available to be issued and other than noted below, no items of significance were noted

Reverse Split. On or about August 3, 2023, the Board of Directors and holders of a majority of the voting power of our company approved a reverse split of our common stock at a ratio of up to 1-for-5,000. We intend to seek approval of such reverse split from FINRA as expeditiously as possible. However, we are unable to predict when FINRA will approve such reverse split.



So, the company itself said the RS was pending on 12-14-23. Then they said it again in the share exchange agreement in February. That's two clear opportunities for them to tell us that the RS isn't happening, but they haven't, and in fact they've said it is.

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.